Literature DB >> 14582874

Globalization and the pharmaceutical industry revisited.

Joan Busfield1.   

Abstract

This survey of the pharmaceutical industry at the beginning of the 21st century updates some of the information provided in Claudio Tarabusi and Graham Vickery's survey, "Globalization in the Pharmaceutical Industry," published in the International Journal of Health Services in 1998, which was largely based on data up to 1993. However, the purpose of the present article differs from that of Tarabusi and Vickery, which covered a wide range of aspects of the industry relevant to globalization but did not explicitly address the question of the extent to which the industry could be described as globalized. After looking at the industry in some detail, the author directly confronts the question of the appropriateness of the use of the term "globalization" for characterizing the directions in which the pharmaceutical industry has been moving.

Mesh:

Substances:

Year:  2003        PMID: 14582874     DOI: 10.2190/262X-56RG-M4T6-1GU5

Source DB:  PubMed          Journal:  Int J Health Serv        ISSN: 0020-7314            Impact factor:   1.663


  3 in total

1.  Towards a genealogy of pharmacological practice.

Authors:  Ricardo Camargo; Nicolás Ried
Journal:  Med Health Care Philos       Date:  2016-03

2.  Peering into the pharmaceutical "pipeline": investigational drugs, clinical trials, and industry priorities.

Authors:  Jill A Fisher; Marci D Cottingham; Corey A Kalbaugh
Journal:  Soc Sci Med       Date:  2014-08-19       Impact factor: 4.634

3.  The Impact of Two-Invoice System on Pharmaceutical Manufacturers' Selling Expenses in China: A Difference-in-Differences Approach.

Authors:  Yi Ran; Yuanyuan Hu; Shouming Chen; Fangjun Qiu; Ahmed Rabeeu
Journal:  Int J Environ Res Public Health       Date:  2022-04-06       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.